Duration of Adalimumab Therapy in Hidradenitis Suppurativa With and Without Oral Immunosuppressants

被引：2
|
作者：
Zubkov, Micaella R. [1 ]
Waldman, Reid A. [2 ]
Wu, Rong [4 ]
Grant-Kels, Jane M. [2 ,3 ]
机构：
[1] Univ Connecticut Sch Med, Farmington, CT USA
[2] Univ Connecticut Hlth Ctr, Dept Dermatol, Farmington, CT 06030 USA
[3] Univ Florida, Dept Dermatol, Gainesville, FL USA
[4] Univ Connecticut, Connecticut Convergence Inst Translat Regenerat E, Farmington, CT USA
来源：
CUTIS | 2021年 / 108卷 / 04期
关键词：
D O I：
10.12788/cutis.0366
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：199 / 200
页数：2
相关论文
共 50 条
  • [41] Hidradenitis suppurativa and adalimumab in the COVID-19 era
    Marzano, Angelo Valerio
    Moltrasio, Chiara
    Genovese, Giovanni
    Muratori, Simona
    Dapavo, Paolo
    Fabbrocini, Gabriella
    Patrizi, Annalisa
    Sechi, Andrea
    Micali, Giuseppe
    Pellegrino, Michele
    Gisondi, Paolo
    Dini, Valentina
    Bianchi, Luca
    Fania, Luca
    Offidani, Annamaria
    Prignano, Francesca
    Atzori, Laura
    Miraglia, Emanuele
    Cannavo, Serafinella Patrizia
    Bettoli, Vincenzo
    Stingeni, Luca
    Balestri, Riccardo
    Venturini, Marina
    Peris, Ketty
    EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (06) : 748 - 749
  • [42] Measuring treatment response to adalimumab in hidradenitis suppurativa patients
    Kok, Y.
    Nicolopoulos, J.
    Dolianitis, C.
    Braue, A.
    Varigos, G.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 52 - 52
  • [43] Adalimumab therapy is associated with increased faecal short chain fatty acids in hidradenitis suppurativa
    Tatian, Artiene
    Bordbar, Sara
    Sarkissian, Samuel Der
    Woods, Jane A.
    Cains, Geoffrey D.
    Chong, Chun Wie
    Marino, Eliana
    Frew, John W.
    EXPERIMENTAL DERMATOLOGY, 2022, 31 (12) : 1872 - 1880
  • [44] Clinical evaluation of adalimumab biosimilar Imraldi in hidradenitis suppurativa
    Prignano, Francesca
    Rosi, Elia
    Fastame, Maria Thais
    Pescitelli, Leonardo
    Di Cesare, Antonella
    Ricceri, Federica
    Pimpinelli, Nicola
    EXPERIMENTAL DERMATOLOGY, 2020, 29 : 43 - 44
  • [45] Clinical experience with adalimumab biosimilar imraldi in hidradenitis suppurativa
    Ricceri, Federica
    Rosi, Elia
    Di Cesare, Antonella
    Pescitelli, Leonardo
    Fastame, Maria Thais
    Prignano, Francesca
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [46] Hematologic Abnormalities in Patients With Hidradenitis Suppurativa Receiving Adalimumab
    Gunter, Simon J.
    Holcomb, Zachary E.
    Lam, Barbara D.
    Porter, Martina L.
    Kimball, Alexa B.
    JAMA DERMATOLOGY, 2024, 160 (06) : 678 - 681
  • [47] Hidradenitis suppurativa and adalimumab in the COVID-19 era
    Angelo Valerio Marzano
    Chiara Moltrasio
    Giovanni Genovese
    Simona Muratori
    Paolo Dapavo
    Gabriella Fabbrocini
    Annalisa Patrizi
    Andrea Sechi
    Giuseppe Micali
    Michele Pellegrino
    Paolo Gisondi
    Valentina Dini
    Luca Bianchi
    Luca Fania
    Annamaria Offidani
    Francesca Prignano
    Laura Atzori
    Emanuele Miraglia
    Serafinella Patrizia Cannavò
    Vincenzo Bettoli
    Luca Stingeni
    Riccardo Balestri
    Marina Venturini
    Ketty Peris
    European Journal of Dermatology, 2020, 30 : 748 - 749
  • [48] Demyelinating disease complicating adalimumab treatment of hidradenitis suppurativa
    Wang, Etienne
    Sen, Priya
    Umapathi, Thirugnanam
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB138 - AB138
  • [49] Adalimumab dose intensification in refractory and flaring hidradenitis suppurativa
    Murray, Gregg
    Mac Mahon, Julie
    Tobin, Anne Marie
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 75 - 75
  • [50] Safety and Efficacy of Adalimumab for Hidradenitis Suppurativa in a Hispanic Population
    Figueroa-Diaz, Adriana
    Medina-Figueroa, Melanie
    Rivera-Criado, Maria
    Cruz-Santana, Alma
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB84 - AB84
12345